Skip to main content

TSEA Energy Selects Eden; Creates 160 Jobs, Invests $25 Million

TSEA Energy, a manufacturer of energy equipment, will establish its first U.S. manufacturing plant in Rockingham County. The company says it will create 160 jobs and invest $25 million in Eden.

The company has been delivering engineered solutions for power generation, transmission, and distribution systems since 1968. Specialized in large power transformers, voltage regulators and mobile substations, TSEA Energy, is recognized for its engineering expertise, with products in operation in more than 50 countries.

TSEA will manufacture its voltage regulators, equipment that supports grid stability, power quality, and system reliability, at a 160,000-square-foot facility in Eden, serving utilities across the United States. The facility is expected to double TSEA’s global manufacturing capacity and will also include an engineering and R&D center, as well as a service center.

While wages vary by position, the annual average salary for the new positions will be $66,554, exceeding Rockingham County’s average of $46,154. These new jobs could potentially create an annual payroll impact of more than $7 million for the region.

https://www.rockinghamcountync.gov/news/6539/governor-stein-announces-brazilian-energy-company-selects-rockingham-county-for-its-first-us-manuf

Reynolds American Commits $3.2 Billion to U.S. Operations; Supports 2,000 Jobs

Reynolds American has announced a forward-looking commitment to invest more than $3.2 billion across its U.S. operations by 2030, reinforcing its long-term focus on value creation and American manufacturing. The investment, which began in 2024, is expected to support more than 2,000 direct and indirect jobs across the company’s operations and U.S. supply network, including roles tied to recent manufacturing expansion and innovation initiatives.

The announcement marks the launch of “Growing Tomorrow,” a campaign focused on driving business performance and delivering sustainable returns while transitioning the organization toward a predominantly smokeless future. A central component of this strategy involves modernizing and expanding research and manufacturing hubs in Winston-Salem, where the company invests approximately $100 million annually in R&D and employs hundreds of scientists.

“Growing Tomorrow reflects the investments we’re making today in American manufacturing and jobs,” said David Waterfield, President and CEO of Reynolds American Inc. “By expanding manufacturing capabilities and strengthening our workforce, we’re building on more than 150 years of investment in the U.S. economy to ensure our competitiveness for the future.”

Reynolds American employs more than 4,300 people across the U.S. in roles spanning advanced manufacturing, engineering, and science. The company remains a cornerstone of the North Carolina agricultural ecosystem; in 2025, it was the largest purchaser of U.S. tobacco leaf from American farmers.

SBA Home Opens First U.S. Factory in Mocksville; Invests $70 Million, Creates 250 Jobs

Lithuanian furniture manufacturer SBA Home has officially opened its first U.S. factory in Mocksville, marking a historic investment exceeding $70 million, the largest Lithuanian business investment in the United States to date. The new facility is expected to create 250 highly skilled jobs while further strengthening economic ties between Lithuania and the U.S. and reinforcing the NC Carolina Core’s status as a hub for advanced manufacturing.

The launch represents a significant milestone for SBA Group, one of the largest furniture manufacturing groups in the Baltics and a partner of IKEA for more than 30 years. While the factory is currently operating one shift, recruitment for a second shift is already underway to increase production volumes for the U.S. market.

https://usa.mfa.lt/en/news/77/largest-lithuanian-investment-in-the-us-sba-home-furniture-manufacturing-facility-officially-opened-in-north-carolina%3A1985?utm_source=chatgpt.com

Altec to Expand in Mount Airy; Create 100 Jobs

Altec will make a significant investment to strengthen its existing operations, result in the creation of 100 new jobs and reinforce Mount Airy’s role as a competitive manufacturing hub.

The project will begin with construction of a new maintenance facility, allowing maintenance staff to relocate from an existing wing of the current building to a new structure adjacent to Altec Way. Once vacated, that portion of the facility will be retooled into additional assembly space, increasing production output and enabling the hiring of more than 100 new associates.

In addition to the new maintenance facility, an addition will be completed in an existing portion of the plant to further expand production capacity. The project will also include utility improvements and facility upgrades to support long-term operational efficiency and growth.

Altec Industries has operated in Mount Airy since its purchase of the facility from Pike Electric in March 2016. Since that time, the company has steadily grown both production capacity and staffing levels, establishing the Mount Airy facility as a key assembly plant within Altec’s national manufacturing network.

https://www.surryedp.com/post/altec-to-bring-significant-capital-investment-and-100-new-jobs-to-mount-airy-through-project-poplar

CorestemChemon Selects Winston-Salem

2/10/26

CorestemChemon, a biopharmaceutical company headquartered in South Korea, has selected Winston-Salem as the location for its U.S. base of operations.

In South Korea, the company has successfully completed clinical trials for Neuronata-R, a stem cell therapy for Amyotrophic Lateral Sclerosis (ALS), making it one of only a small number of stem cell therapies approved for use globally. From its U.S. base in Winston-Salem, CorestemChemon plans to advance its therapies through U.S. regulatory pathways while building research, clinical and business partnerships.

“Establishing our U.S. operations in Winston-Salem represents an important milestone in CorestemChemon’s global strategy,” said Seung Beom Yang, director of CorestemChemon. “The opportunity to work within the RegenMed Engine and alongside the Wake Forest Institute for Regenerative Medicine (WFIRM), the world’s leading translational regenerative medicine institution, provides a strong foundation for expanding our therapies into the U.S. market and increasing our impact for patients worldwide.”